Given the limitations of both LAIV and IIV, how will alternative vaccine delivery routes (e.g. microneedle patch, etc.) change the landscape of influenza vaccine products – specifically with regard to the impact on LAIV – in the pediatric population? Are any new LAIV formulations in the pipeline?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.